Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.510
+0.130 (5.46%)
At close: Mar 9, 2026, 4:00 PM EDT
2.500
-0.010 (-0.40%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Absci Revenue
Absci had revenue of $378.00K in the quarter ending September 30, 2025, a decrease of -77.78%. This brings the company's revenue in the last twelve months to $2.82M, down -33.09% year-over-year. In the year 2024, Absci had annual revenue of $4.53M, down -20.71%.
Revenue (ttm)
$2.82M
Revenue Growth
-33.09%
P/S Ratio
134.08
Revenue / Employee
$17,930
Employees
157
Market Cap
377.43M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ginkgo Bioworks Holdings | 170.16M |
| Bicycle Therapeutics | 28.34M |
| Foghorn Therapeutics | 24.52M |
| LENZ Therapeutics | 17.50M |
| Aclaris Therapeutics | 7.83M |
| Shattuck Labs | 1.00M |
| Neurogene | 925.00K |
ABSI News
- 3 days ago - Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 days ago - Absci Corporation (ABSI) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 6 days ago - Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer - GlobeNewsWire
- 13 days ago - Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 - GlobeNewsWire
- 20 days ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Absci Corporation (ABSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Absci Corporation (ABSI) Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia Transcript - Seeking Alpha